insights_auto
Why is GH up 2,08%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
169,00 $
arrow_upward
+2,08%(+3,44) 1D
9 հոկ, 12:02:56 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
166,03 $
High
170,81 $
Low
166,03 $
Mkt. cap
22,68 մլրդ
Avg. vol.
1,87 մլն
Volume
465,13 հզր
52-wk high
191,01 $
52-wk low
61,00 $
EPS
-3,50 $
Beta
1,58
Shares outstanding
134,20 մլն
No. of employees
2 հզր
Open
166,03 $
High
170,81 $
Low
166,03 $
Mkt. cap
22,68 մլրդ
Avg. vol.
1,87 մլն
Volume
465,13 հզր
52-wk high
191,01 $
52-wk low
61,00 $
EPS
-3,50 $
Beta
1,58
Shares outstanding
134,20 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Yahoo Finance
·
24 րոպե առաջ
Grail (GRAL) vs Guardant Health (GH): Which is a Better Stock to Buy?
Investing.com
·
18 ժամ առաջ
Guardant Health receives European approval for breast cancer test
Stock Titan
·
19 ժամ առաջ
A blood test in Europe can help identify who may benefit from AstraZeneca’s breast cancer drug
Yahoo Finance
·
19 ժամ առաջ
Guardant Health to Report Third Quarter 2026 Financial Results on November 5, 2026
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 հզր
Founded2012
HeadquartersՊալո Ալտո, Կալիֆոռնիա, Միացյալ Նահանգներ
SectorHealth care provider
Websiteguardanthealth.com